Vast Ventures is a venture capital fund that focuses on investing in Seed, Series A, and growth stages. The firm targets disruptive companies with a global impact, aiming to improve worldwide health and happiness, promote resource sustainability, increase human potential and productivity, and enhance knowledge, empathy, and connectedness. Their investments span various sectors and geographies, reflecting their broad commitment to fostering innovation and positive change.

Notable portfolio companies include Asapp, Clover Health, Ginkgo Bioworks, and Sweetgreen. The firm is led by key partners who bring extensive experience from previous affiliations with successful ventures. Vast Ventures distinguishes itself through a manifesto-driven investment philosophy, emphasizing long-term societal benefits alongside financial returns. They offer unique value-add services to their portfolio companies, such as strategic guidance and access to a robust network of industry experts and resources.